UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER
Clinical trials for UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immunotherapy combo aims to improve lung cancer outcomes
Disease control Not yet recruitingThis phase II trial tests an immunotherapy drug called SHR-1701 combined with chemotherapy and radiation for people with unresectable stage III non-small cell lung cancer. The study will enroll 84 participants and compare giving SHR-1701 before or after standard chemoradiation. T…
Matched conditions: UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo aims to turn untreatable lung tumors into surgical candidates
Disease control Not yet recruitingThis phase 2 trial tests whether combining the immunotherapy drug tislelizumab with standard chemotherapy and a targeted chemo-blocking procedure (BACE) can shrink advanced, inoperable stage III non-small cell lung cancer enough to allow surgery. About 39 participants will receiv…
Matched conditions: UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC